# Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions

> **NCT03901079** · — · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 20 (actual)

## Conditions studied

- CAD

## Interventions

- **OTHER:** single-arm study

## Key facts

- **NCT ID:** NCT03901079
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-08
- **Primary completion:** 2020-01-10
- **Final completion:** 2021-03-24
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** HGRAC approval letter had expired. The enrollment speed of FAST CTO is much slower than planning and the scientific value becomes limited due to the delayed data readout anticipation.
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03901079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03901079, "Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03901079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*